Previous studies showed that EA exerts anti-angiogenic effects in breast cancer inhibiting VEGFR-2 signaling; these findings were supported by the results of an in silico analysis suggesting a possible interaction between VEGFR-2 and the polyphenol [16]. Here, KDR is linked to breast cancer.